Castro et al.137 observed that in glioblastoma, depletion of VEGF induced by bevacizumab downregulated macrophage migration inhibitory factor (MIF) at the tumor margin, leading to the proliferative expansion of M2-like TAMs. The gene discussed is VEGFA; the disease is neoplasm.